Alyeska Investment Group
NVO

Alyeska Investment Group’s Novo Nordisk NVO Stock Holding History

Alyeska Investment Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,684
Closed -$356K – 754
2026
Q1 		$356K Buy
+9,684
New +$459K ﹤0.01% 595
2025
Q1 		– Sell
-209,866
Closed -$18.1M – 619
2024
Q4 		$18.1M Sell
209,866
-608,019
-74% -$65.8M 0.07% 269
2024
Q3 		$97.4M Buy
817,885
+560,893
+218% +$74.8M 0.5% 54
2024
Q2 		$36.7M Buy
+256,992
New +$34.1M 0.21% 139
2023
Q1 		– Sell
-776,180
Closed -$52.5M – 520
2022
Q4 		$52.5M Sell
776,180
-159,438
-17% -$9.35M 0.54% 59
2022
Q3 		$46.6M Sell
935,618
-1,032,288
-52% -$55.3M 0.54% 59
2022
Q2 		$110M Buy
1,967,906
+166,994
+9% +$9.27M 1.25% 9
2022
Q1 		$100M Buy
1,800,912
+869,682
+93% +$44.6M 1.1% 9
2021
Q4 		$52.1M Buy
931,230
+3,182
+0.3% +$172K 0.6% 52
2021
Q3 		$44.6M Buy
928,048
+561,930
+153% +$27.2M 0.55% 46
2021
Q2 		$15.3M Sell
366,118
-483,882
-57% -$18.8M 0.18% 160
2021
Q1 		$28.7M Buy
+850,000
New +$30.3M 0.37% 75
2020
Q1 		– Sell
-2,149,110
Closed -$62.2M – 441
2019
Q4 		$62.2M Sell
2,149,110
-202,440
-9% -$5.61M 0.82% 30
2019
Q3 		$60.8M Buy
2,351,550
+1,485,828
+172% +$37.6M 0.88% 26
2019
Q2 		$22.1M Buy
865,722
+265,722
+44% +$6.57M 0.29% 114
2019
Q1 		$15.7M Buy
+600,000
New +$14.7M 0.21% 137

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Alyeska Investment Group's NVO Position: Q2 2026 in Review

Alyeska Investment Group sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 9,684 shares — an estimated $356K sold.

Alyeska Investment Group first reported a position in NVO in Q1 2019 and held it in 16 quarters. The position peaked at $110M in Q2 2022. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Alyeska Investment Group reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 9,684 Novo Nordisk shares in Q2 2026, an estimated $356K.
  • Alyeska Investment Group first reported a position in Novo Nordisk in Q1 2019 and held it in 16 quarters.
  • Alyeska Investment Group's Novo Nordisk position peaked at $110M in Q2 2022.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.